Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
Staphylococcus aureus is a ubiquitous human commensal pathogen. It is commonly isolated in cystic fibrosis (CF) patients and is considered one of the main causes of the recurrent acute pulmonary infections and progressive decline in lung function that characterize this inherited life-threatening mul...
Main Authors: | Susanna Esposito, Guido Pennoni, Valeria Mencarini, Nicola Palladino, Laura Peccini, Nicola Principi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00849/full |
Similar Items
-
A Peculiar Case of Pneumonia due to <i>Mycoplasma pneumoniae</i> in a Child with Cystic Fibrosis and Sensibilization to <i>Aspergillus fumigatus</i>
by: Laura Peccini, et al.
Published: (2019-12-01) -
Long-Term Intrahost Evolution of Methicillin Resistant Staphylococcus aureus Among Cystic Fibrosis Patients With Respiratory Carriage
by: Taj Azarian, et al.
Published: (2019-06-01) -
Genomic information on multidrug-resistant livestock-associated methicillin-resistant Staphylococcus aureus ST398 isolated from a Brazilian patient with cystic fibrosis
by: Danielle F Lima, et al. -
Emergence and spread of worldwide Staphylococcus aureus clones among cystic fibrosis patients
by: Garbacz K, et al.
Published: (2018-02-01) -
Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections
by: Kuan-Yi Lu, et al.
Published: (2023-02-01)